Post-earnings recap
Reported
Thu, Oct 23, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $1.10, slightly beating expectations, which contributed to a positive stock reaction of 2.73%. However, there was no revenue data provided, leaving some uncertainty about overall performance. Investors may view the EPS beat as a sign of resilience in the company's operations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.10 | N/A | +2.23% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.